Related Experiment Video
Updated: Feb 16, 2026
07:27
Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
204
Pneumonectomy in pulmonary metastasis
Noriyuki Matsutani1, Sakae Okumura2, Ichiro Yoshino3
1Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Journal of Thoracic Disease
|December 23, 2017
Summary
Pneumonectomy for lung metastases has a low 5-year survival rate (28.9%). Age 55+ and lymph node metastasis predict poor outcomes, necessitating careful patient selection for this lung surgery.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Pneumonectomy carries a high risk of complications, demanding careful consideration before surgical intervention.
- This study evaluates outcomes for patients undergoing pneumonectomy for metastatic lung tumors.
Purpose of the Study:
- To analyze survival parameters and prognostic factors in patients who underwent pneumonectomy for lung metastases.
- To identify patient characteristics associated with poorer prognosis after pneumonectomy.
Main Methods:
- Retrospective multicenter study using data from the Metastatic Lung Tumor Study Group of Japan (1984-2013).
- Analysis of 55 patients who underwent pneumonectomy as part of pulmonary metastasectomy (out of 4,742 patients).
- Evaluation of survival rates and prognostic factors through univariate and multivariate analyses.
Main Results:
- The overall 5-year survival rate after pneumonectomy was 28.9%, significantly lower than other metastasectomy procedures (53.4%).
- Hospital mortality was 5.45% (3/55).
- Age 55 years or older and lymph node metastasis were significant predictors of poor prognosis, with age being an independent factor.
Conclusions:
- Pneumonectomy for lung metastases should be carefully indicated, particularly for patients aged 55 and older.
- Consideration of primary tumor characteristics is also important when deciding on pneumonectomy.
